Smith Lawrence Russell

VP, Vaccine Research at VICAL INC

Sold, on record
$43k
Dollars the filings state
Form 4 sales
15
Latest Mar 15, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale VICAL INCPlan not stated
    Oct 12, 2015 2015

    Sold 974 shares at $0.43 ($419)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 0.4% of holdings ($105k position)242,055 shares left0.5x usual sizeFiling

  2. 2 Form 4 sale VICAL INCPlan not stated
    Jan 11, 2016 +91 days

    Sold 974 shares at $0.36 ($351)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 0.4% of holdings ($87k position)241,081 shares left0.5x usual sizeFiling

  3. 3 Form 4 sale VICAL INCUnusual
    Mar 15, 2016 +64 days

    Sold 8,750 shares at $0.41 ($4k)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 3.6% of holdings ($99k position)232,331 shares left4.6x usual sizeFiling

  4. 4 Form 4 sale VICAL INCPlan not stated
    Jul 11, 2016 +118 days

    Sold 54 shares at $4.46 ($241)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 0.2% of holdings ($104k position)23,179 shares left0x usual sizeFiling

  5. 5 Form 4 sale VICAL INCPlan not stated
    Oct 11, 2016 +92 days

    Sold 54 shares at $3.05 ($165)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 0.2% of holdings ($71k position)23,125 shares left0.1x usual sizeFiling

  6. 6 Form 4 sale VICAL INCPlan not stated
    Jan 11, 2017 +92 days

    Sold 54 shares at $2.48 ($134)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 0.2% of holdings ($57k position)23,071 shares left0.1x usual sizeFiling

  7. 7 Form 4 sale VICAL INCUnusual
    Feb 10, 2017 +30 days

    Sold 4,500 shares at $2.26 ($10k)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 19.5% of holdings ($52k position)18,571 shares left4.6x usual sizeFiling

  8. 8 Form 4 sale VICAL INCPlan not stated
    Mar 15, 2017 +33 days

    Sold 875 shares at $2.31 ($2k)

    Smith Lawrence Russell, VP, Vaccine Research

    Sold 4.7% of holdings ($43k position)17,696 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Smith Lawrence Russell
Source
Mar 15, 2017Mar 17, 2017VICAL INCVP, Vaccine ResearchForm 4 sale875$2k4.7%Plan not statedSEC
Feb 10, 2017Feb 14, 2017VICAL INCVP, Vaccine ResearchForm 4 sale4,500$10k19.5%UnusualSEC
Jan 11, 2017Jan 13, 2017VICAL INCVP, Vaccine ResearchForm 4 sale54$1340.2%Plan not statedSEC
Oct 11, 2016Oct 12, 2016VICAL INCVP, Vaccine ResearchForm 4 sale54$1650.2%Plan not statedSEC
Jul 11, 2016Jul 13, 2016VICAL INCVP, Vaccine ResearchForm 4 sale54$2410.2%Plan not statedSEC
Mar 15, 2016Mar 17, 2016VICAL INCVP, Vaccine ResearchForm 4 sale8,750$4k3.6%UnusualSEC
Jan 11, 2016Jan 13, 2016VICAL INCVP, Vaccine ResearchForm 4 sale974$3510.4%Plan not statedSEC
Oct 12, 2015Oct 14, 2015VICAL INCVP, Vaccine ResearchForm 4 sale974$4190.4%Plan not statedSEC
Jul 13, 2015Jul 15, 2015VICAL INCVP, Vaccine ResearchForm 4 sale974$6820.4%Plan not statedSEC
Apr 13, 2015Apr 15, 2015VICAL INCVP, Vaccine ResearchForm 4 sale974$9060.4%Plan not statedSEC
Jan 12, 2015Jan 14, 2015VICAL INCVP, Vaccine ResearchForm 4 sale1,912$2k1.1%Plan not statedSEC
Oct 13, 2014Oct 14, 2014VICAL INCVP, Vaccine ResearchForm 4 sale1,912$2k1.1%Plan not statedSEC
Aug 26, 2014Aug 27, 2014VICAL INCVP, Vaccine ResearchForm 4 sale12,500$16k6.5%Plan not statedSEC
Jul 11, 2014Jul 15, 2014VICAL INCVP, Vaccine ResearchForm 4 sale1,912$2k1.0%Plan not statedSEC
Apr 11, 2014Apr 14, 2014VICAL INCVP, Vaccine ResearchForm 4 sale1,912$2k1.0%Plan not statedSEC